Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $218.18 in the prior trading day, CME Group Inc (NASDAQ: CME) closed at $216.30, down -0.86%. In other words, the price has decreased by -$0.86 from its previous closing price. On the day, 1.73 million shares were traded. CME stock price reached its highest trading level at $218.36 during the session, while it also had its lowest trading level at $214.94.
Ratios:
Our goal is to gain a better understanding of CME by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 40.64 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 22.31. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on September 03, 2024, Downgraded its rating to Underperform and sets its target price to $177 from $212 previously.
On June 21, 2024, JP Morgan Downgraded its rating to Underweight which previously was Neutral and also lowered its target price recommendation from $206 to $187.
Barclays Downgraded its Overweight to Equal Weight on January 08, 2024, whereas the target price for the stock was revised from $244 to $222.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 15 ’24 when Fitzpatrick Lynne sold 754 shares for $216.99 per share. The transaction valued at 163,610 led to the insider holds 13,261 shares of the business.
Durkin Bryan T sold 7,593 shares of CME for $1,629,382 on Aug 30 ’24. The Director now owns 55,607 shares after completing the transaction at $214.59 per share. On Aug 30 ’24, another insider, Durkin Bryan T, who serves as the Officer of the company, bought 7,593 shares for $213.52 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CME now has a Market Capitalization of 77888978944 and an Enterprise Value of 79827329024. As of this moment, CME’s Price-to-Earnings (P/E) ratio for their current fiscal year is 23.86, and their Forward P/E ratio for the next fiscal year is 21.52. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 8.14. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.44 while its Price-to-Book (P/B) ratio in mrq is 2.81. Its current Enterprise Value per Revenue stands at 13.792 whereas that against EBITDA is 19.906.
Stock Price History:
Over the past 52 weeks, CME has reached a high of $222.63, while it has fallen to a 52-week low of $190.70. The 50-Day Moving Average of the stock is 4.89%, while the 200-Day Moving Average is calculated to be 4.22%.
Shares Statistics:
The stock has traded on average 2.22M shares per day over the past 3-months and 2325160 shares per day over the last 10 days, according to various share statistics. A total of 359.23M shares are outstanding, with a floating share count of 358.90M. Insiders hold about 0.33% of the company’s shares, while institutions hold 88.62% stake in the company. Shares short for CME as of 1724976000 were 3885704 with a Short Ratio of 1.75, compared to 1722384000 on 3463340. Therefore, it implies a Short% of Shares Outstanding of 3885704 and a Short% of Float of 1.08.
Dividends & Splits
In the trailing 12 months, CME’s forward annual dividend rate was 4.5, compared to 4.55 this year. Against a Trailing Annual Dividend Yield of 0.020625172The stock’s 5-year Average Dividend Yield is 3.18.
